Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology
- Author:
Jung Hee KIM
1
;
Hyun Wook CHAE
;
Sang Ouk CHIN
;
Cheol Ryong KU
;
Kyeong Hye PARK
;
Dong Jun LIM
;
Kwang Joon KIM
;
Jung Soo LIM
;
Gyuri KIM
;
Yun Mi CHOI
;
Seong Hee AHN
;
Min Ji JEON
;
Yul HWANGBO
;
Ju Hee LEE
;
Bu Kyung KIM
;
Yong Jun CHOI
;
Kyung Ae LEE
;
Seong-Su MOON
;
Hwa Young AHN
;
Hoon Sung CHOI
;
Sang Mo HONG
;
Dong Yeob SHIN
;
Ji A SEO
;
Se Hwa KIM
;
Seungjoon OH
;
Sung Hoon YU
;
Byung Joon KIM
;
Choong Ho SHIN
;
Sung-Woon KIM
;
Chong Hwa KIM
;
Eun Jig LEE
Author Information
- Publication Type:Special Article
- From:Endocrinology and Metabolism 2020;35(2):272-287
- CountryRepublic of Korea
- Language:0
- Abstract: Growth hormone (GH) deficiency is caused by congenital or acquired causes and occurs in childhood or adulthood. GH replacement therapy brings benefits to body composition, exercise capacity, skeletal health, cardiovascular outcomes, and quality of life. Before initiating GH replacement, GH deficiency should be confirmed through proper stimulation tests, and in cases with proven genetic causes or structural lesions, repeated GH stimulation testing is not necessary. The dosing regimen of GH replacement therapy should be individualized, with the goal of minimizing side effects and maximizing clinical improvements. The Korean Endocrine Society and the Korean Society of Pediatric Endocrinology have developed a position statement on the diagnosis and treatment of GH deficiency. This position statement is based on a systematic review of evidence and expert opinions.
